Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Chemotherapy|December 6, 2021
Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia: A Serologic and Cellular StudyStefano Molica, Diana Giannarelli, Mirella Lentini, et al.
Leukemia Research|July 27, 2014
Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO GroupAntonio Cuneo, Monia Marchetti, Giovanni Barosi, et al.
International Journal of Hematology|September 27, 2008
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemiaStefano Molica, Gaetano Vitelli, Giovanna Cutrona, et al.
Hematological Oncology|February 28, 2009
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLLLilla Cro, Fortunato Morabito, Nadia Zucal, et al.
Leukemia & Lymphoma|July 21, 2005
A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemiaStefano Molica, Francesca R Mauro, Vincenzo Callea, et al.
Cancer|November 25, 2003
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio LinfomiPaolo G Gobbi, Chiara Broglia, Francesco Merli, et al.
Tumori|November 11, 2003
Differences in transplant-related complications between hematologic malignancies and solid tumors receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantationMassimo Martino, Fortunato Morabito, Giuseppe Console, et al.
Cytotherapy|July 20, 2015
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patientsMassimo Martino, Anna Grazia Recchia, Tiziana Moscato, et al.
Leukemia & Lymphoma|April 11, 2003
Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL)Marco Lombardo, Fortunato Morabito, Francesco Merli, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2014
Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimenRoberta Fedele, Giuseppe Messina, Tiziana Martinello, et al.
Pageof 16